Genotype-stratified treatment for monogenic insulin resistance: a systematic review.

Robert K SempleKashyap Amratlal PatelSungyoung Auhnull nullRebecca J Brown
Published in: Communications medicine (2023)
The evidence guiding genotype-specific treatment of monogenic IR is of low to very low quality. Metreleptin and Thiazolidinediones appear to improve metabolic markers in lipodystrophy, and rhIGF-1 appears to lower HbA1c in INSR-related IR. For other interventions, there is insufficient evidence to assess efficacy and risks in aggregated lipodystrophy or genetic subgroups.